The aim of this study is to report the clinicopathologic characteristics of 3 cases of alveolar rhabdomyosarcoma with neuroendocrine/neuronal differentiation. Specimens of 3 cases of alveolar rhabdomyosarcoma were studied using histologic, immunohistochemical, ultrastructural, and molecular genetic techniques. The patients were a 19-year-old man with metastatic alveolar rhabdomyosarcoma in a groin lymph node, a 16-year-old girl with alveolar rhabdomyosarcoma of the perineum, and a 20-year-old man with recurrent orbital alveolar rhabdomyosarcoma. Microscopically, case 1 was composed of compact sheets of medium to large tumor cells. Cases 2 and 3 were small blue round cell tumors. Cases 1 and 3 were solid throughout, whereas case 2 demonstrated alveolar and solid architecture. By immunohistochemistry, the following markers were positive: desmin (3/3), myogenin (3/3), synaptophysin (3/3), and chromogranin (2/3). Ultrastructurally, sarcomeric filaments were seen in all cases, while neuroendocrine granules were detected only in case 1. PAX:FKHR fusion transcript was identified in case 2, case 3 had a variant PAX3 transcript, and case 1 was negative. The data presented expands the known differentiation of alveolar rhabdomyosarcoma.
Weiss S., Goldblum J.Primitive neuroectodermal tumors and related lesions. In: Weiss S, Goldblum J, eds. Enzinger and Weiss Soft Tissue Tumors. 4th ed. St. Louis, Mo: Mosby; 2001.
2.
Pagani A., Macri L., Rosolen A., et al. Neuroendocrine differentiation in Ewing's sarcomas and primitive neuroectodermal tumors revealed by reverse transcriptasepolymerase chain reaction of chromogranin mRNA. Diagn Mol Pathol. 1998 ;7:36-43.
3.
Herrera GA, Cerezo L., Jones JE, et al. Gastrointestinal autonomic nerve tumors. "Plexosarcomas." Arch Pathol Lab Med.1989;113:846-853.
4.
Oliveira AM, Sebo TJ, McGrory JE, et al. Extraskeletal myxoid chondrosarcoma: a clinicopathologic, immunohistochemical, and ploidy analysis of 23 cases. Mod Pathol. 2000;13:900-908.
5.
Harris M., Coyne J., Tariq M., et al. Extraskeletal myxoid chondrosarcoma with neuroendocrine differentiation: a pathologic, cytogenetic, and molecular study of a case with a novel translocation t(9;17)(q22;q11.2). Am J Surg Pathol.2000 ;24:1020-1026.
6.
Goh YW, Spagnolo DV, Platten M., et al. Extraskeletal myxoid chondrosarcoma: a light microscopic, immunohistochemical, ultrastructural, and immuno-ultrastructural study indicating neuroendocrine differentiation. Histopathology. 2001;39:514-524.
7.
Domanski HA, Carlen B., Mertens F., et al. Extraskeletal myxoid chondrosarcoma with neuroendocrine differentiation: a case report with fine-needle aspiration biopsy, histopathology, electron microscopy, and cytogenetics. Ultrastruct Pathol. 2003;27:363-368.
8.
Dickersin GRThe electron microscopic spectrum of nerve sheath tumors. Ultrastruct Pathol. 1987;11:103-146.
9.
Christensen WN, Strong EW, Bains MS, et al. Neuroendocrine differentiation in the glandular peripheral nerve sheath tumor. Pathologic distinction from the biphasic synovial sarcoma with glands. Am J Surg Pathol.1988;12:417-426.
Karcioglu Z. , Someren A., Mathes SJEctomesenchymoma: a malignant tumor of migratory neural crest (ectomesenchyme) remnants showing ganglionic, schwannian, melanocytic, and rhabdomyoblastic differentiation . Cancer. 1977;39:2486-2496.
12.
Kawamoto EH , Weidner N., Agostini RM Jr, et al. Malignant ectomesenchymoma of soft tissue report of 2 cases and review of the literature . Cancer . 1987;59: 1791-1802.
13.
Kosem M., Ibiloglu I., Bakan V., et al. Ectomesenchymoma: case report and review of the literature. Turk J Pediatr. 2004;46:82-87.
14.
DeLellis A., Dayal Y.Neuroendocrine system. In: Sternberg SS, ed. Histology for Pathologists. New York, NY: Raven Press;1992 :347-362.
15.
Ordóñez NG, Mackay B.Neuroendocrine tumors of the nasal cavity. Pathol Annu. 1993;28:77-111.
16.
Burke AP, Helwig EBGangliocytic paraganglioma. Am J Clin Pathol. 1989;92:1-9.
17.
Freeman JK, Otis CNCombined carcinoid tumor and ganglioneuroblastoma of the lung: a case report . Int J Surg Pathol. 2001;9:169-173.
18.
Edwards RH, Chatten J., Xiong QB, Barr FGDetection of gene fusions in rhabdomyosarcoma by reverse transcriptase-polymerase chain reaction assay of archival samples. Diagn Mol Pathol . 1997;6:91-97.
19.
Nishio J., Althof PA, Bailey JM, et al. Use of a novel FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of alveolar rhabdomyosarcoma. Lab Invest . 2006;86:547-556.
20.
Weiss S., Goldblum J.Rhabdomyosarcoma. In: Weiss S , Goldblum J, eds. Enzinger and Weiss Soft Tissue Tumors. 4ed. St. Louis, Mo: Mosby; 2001.
21.
Barr FG, Qualman SJ, Macris MH, et al. Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusions. Cancer Res. 2002;62: 4704-4710.
22.
Parham DM, Qualman SJ, Teot L., et al. Correlation between histology and PAX/FKHR fusion status in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group. Am J Surg Pathol. 2007;31:895-901.
23.
Rosai J.An evolutionary view of neuroendocrine cells and their tumors. Int J Surg Pathol. 2001;9:87-92.
24.
Abbona GPM , Viberti L., Macri L., et al. Chromogranin A gene expression in non-small cell lung carcinomas. J Pathol . 1998;186:151-156.
25.
Axe S., Kuhajda FPEsthesioneuroblastoma. Intermediate filaments, neuroendocrine, and tissue-specific antigens. Am J Clin Pathol.1987;88:139-145.
26.
Shimada S., Tsuzuki T., Kuroda M., et al. Nestin expression as a new marker in malignant peripheral nerve sheath tumors. Pathol Int. 2007;57:60-67.
27.
Schilstra A. , van Tuijl JH, van Suylen RJ, et al. Unclassified rhabdomyosarcoma in a patient with anti-Hu syndrome . Acta Clin Belg. 2005;60:248-251.
28.
Mechtersheimer G., Staudter M., Moller P.Expression of the natural killer cell-associated antigens CD56 and CD57 in human neural and striated muscle cells and in their tumors. Cancer Res. 1991;51:1300-1307.
29.
Leader M., Collins M., Patel J., Henry K.Antineuron specific enolase staining reactions in sarcomas and carcinomas: its lack of neuroendocrine specificity. J Clin Pathol. 1986;39:1186-1192.
30.
Campbell LK , Thomas JR, Lamps LW, et al. Protein gene product 9.5 (PGP 9.5) is not a specific marker of neural and nerve sheath tumors: an immunohistochemical study of 95 mesenchymal neoplasms. Mod Pathol.2003;16:963-969.
31.
Folpe AL, Patterson K., Gown A.Antineuroblastoma antibody NB-84 also identifies significant subset of other small blue round cell tumors. Appl Immunohistochem. 1997;5:239-245.
32.
Gultekin SH , Rosai J., Demopoulos A., et al. Hu immunolabeling as a marker of neural and neuroendocrine differentiation in normal and neoplastic human tissues: assessment using a recombinant anti-Hu fab fragment. Int J Surg Pathol. 2000;8:109-117.
33.
Sorensen PH , Shimada H., Liu XF, et al. Biphenotypic sarcomas with myogenic and neural differentiation express the Ewing's sarcoma EWS/FLI1 fusion gene . Cancer Res. 1995;55:1385-1392.
34.
De Alava E. , Lozano MD, Sola I., et al. Molecular features in a biphenotypic small cell sarcoma with neuroectodermal and muscle differentiation . Hum Pathol. 1998;29:181-184.
35.
Goldsmith JD , Pawel B., Goldblum JR, et al. Detection and diagnostic utilization of placental alkaline phosphatase in muscular tissue and tumors with myogenic differentiation. Am J Surg Pathol . 2002;26:1627-1633.
Ferreiro J. , Lewin K., Herron RM, et al. Malignant islet cell tumor with rhabdomyosarcomatous differentiation. Am J Surg Pathol. 1989;13:422-427.
38.
Doglioni C. , Ferlito A., Chiamente C., et al. Laryngeal carcinoma showing multidirectional epithelial neuroendocrine and sarcomatous differentiation . ORL J Otorhinolaryngol Relat Spec. 1990 ;52:316-326.
39.
Roncaroli F. , Montironi R., Feliciotti F., et al. Sarcomatoid carcinoma of the anorectal junction with neuroendocrine and rhabdomyoblastic features. Am J Surg Pathol. 1995;19:217-223.
40.
Eusebi V., Damiani S., Pasquinelli G., et al. Small cell neuroendocrine carcinoma with skeletal muscle differentiation: report of 3 cases. Am J Surg Pathol. 2000;24:223-230.
41.
Miettinen M. , Rapola J.Immunohistochemical spectrum of rhabdomyosarcoma and rhabdomyosarcoma-like tumors. Expression of cytokeratin and the 68-kD neuro-filament protein. Am J Surg Pathol. 1989;13:120-132.
